Savior Lifetec Corporation announced on Oct 3, 2014 that the active pharmaceutical ingredient (API) manufacturing facility in Tainan, Taiwan has been granted "acceptable" status under the FDA's regulatory guidelines. The cGMP inspection by the US Food and Drug Administration (FDA) was completed during the period of May 12-16, 2014.